FDA-cleared blood tests are streamlining Alzheimer’s diagnosis while a new study suggests a single blood biomarker might predict symptom onset age.
Longevity News
Newly FDA-cleared blood tests are now making it easier for doctors to diagnose Alzheimer’s disease.
Source: FierceBiotech - All • Published: 19 Feb 2026, 15:24
Continue exploring
Related longevity signals
Frontiers - HealthThe Application Progress of Artificial Intelligence in the Diagnosis of Alzheimer's DiseaseSurvey of how machine learning and deep learning are being applied to neuroimaging and multi-omics for earlier, automated Alzheimer's diagnosis and staging.Fight Aging!Trial Results for a PD-L1 Antibody Therapy to Reduce Inflammation in Alzheimer's DiseaseA preview of an article about a clinical trial testing a PD‑L1 antibody as an anti‑inflammatory approach for early Alzheimer's disease, inviting readers curious about novel therapeutic strategies.Frontiers - HealthImpact of Anatomic Complexity of Congenital Heart Disease on Growth Retardation: A Large Retrospective Cohort StudyAssessing how anatomic complexity in congenital heart disease relates to growth retardation in a large pediatric retrospective cohort and a predictive nomogram.Longevity TechnologyIonis, Biogen deliver new tau data in Alzheimer’sThis article previews a news piece about new clinical trial results for a tau-targeting Alzheimer’s therapy, highlighting study type and implications for the field.